These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 9779879

  • 1. Topotecan in the treatment of hematologic malignancies.
    Beran M, Kantarjian H.
    Semin Hematol; 1998 Jul; 35(3 Suppl 4):26-31. PubMed ID: 9779879
    [Abstract] [Full Text] [Related]

  • 2. Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Beran M, Estey E, O'Brien SM, Giles FJ, Koller CA, Kornblau S, Keating M, Kantarjian HM.
    Leuk Lymphoma; 1998 Nov; 31(5-6):521-31. PubMed ID: 9922042
    [Abstract] [Full Text] [Related]

  • 3. Results of topotecan-based combination therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Beran M, Kantarjian H.
    Semin Hematol; 1999 Oct; 36(4 Suppl 8):3-10. PubMed ID: 10622223
    [Abstract] [Full Text] [Related]

  • 4. Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia.
    Beran M, Kantarjian H, O'Brien S, Koller C, al-Bitar M, Arbuck S, Pierce S, Moore M, Abbruzzese JL, Andreeff M, Keating M, Estey E.
    Blood; 1996 Oct 01; 88(7):2473-9. PubMed ID: 8839838
    [Abstract] [Full Text] [Related]

  • 5. Activity of 9-nitro-camptothecin, an oral topoisomerase I inhibitor, in myelodysplastic syndrome and chronic myelomonocytic leukemia.
    Quintas-Cardama A, Kantarjian H, O'Brien S, Jabbour E, Giles F, Ravandi F, Faderl S, Pierce S, Shan J, Verstovsek S, Cortes J.
    Cancer; 2006 Oct 01; 107(7):1525-9. PubMed ID: 16955510
    [Abstract] [Full Text] [Related]

  • 6. Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Beran M, Estey E, O'Brien S, Cortes J, Koller CA, Giles FJ, Kornblau S, Andreeff M, Vey N, Pierce SR, Hayes K, Wong GC, Keating M, Kantarjian H.
    J Clin Oncol; 1999 Sep 01; 17(9):2819-30. PubMed ID: 10561358
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phase I/II clinical study of topotecan and cytarabine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia and acute myeloid leukemia.
    Weihrauch MR, Staib P, Seiberlich B, Hoffmann M, Diehl V, Tesch H.
    Leuk Lymphoma; 2004 Apr 01; 45(4):699-704. PubMed ID: 15160942
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
    Cortes J, Giles F, O'Brien S, Thomas D, Albitar M, Rios MB, Talpaz M, Garcia-Manero G, Faderl S, Letvak L, Salvado A, Kantarjian H.
    Cancer; 2003 Jun 01; 97(11):2760-6. PubMed ID: 12767088
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome.
    Kantarjian H, Beran M, Cortes J, O'Brien S, Giles F, Pierce S, Shan J, Plunkett W, Keating M, Estey E.
    Cancer; 2006 Mar 01; 106(5):1099-109. PubMed ID: 16435387
    [Abstract] [Full Text] [Related]

  • 12. Incorporating new modalities into guidelines. Topotecan for myelodysplastic syndromes.
    Estey EH.
    Oncology (Williston Park); 1998 Nov 01; 12(11A):81-6. PubMed ID: 10028504
    [Abstract] [Full Text] [Related]

  • 13. [Long-term effects of androgen combined with low dose all-trans-retinoic acid on myelodysplastic syndrome: follow-up of 60 cases].
    Guan M, Chen SC, Ge CW.
    Zhonghua Yi Xue Za Zhi; 2009 Apr 07; 89(13):919-22. PubMed ID: 19671296
    [Abstract] [Full Text] [Related]

  • 14. New agents for the treatment of acute myelogenous leukemia: focus on topotecan and retinoids.
    Estey EH.
    Leukemia; 1998 Sep 07; 12 Suppl 1():S13-5. PubMed ID: 9777888
    [Abstract] [Full Text] [Related]

  • 15. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N, Bornhäuser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schäfer-Eckardt K, Beyer J, Kiehl M, Zander AR, German Cooperative Transplant Study Group.
    Ann Hematol; 2003 Jun 07; 82(6):336-42. PubMed ID: 12728337
    [Abstract] [Full Text] [Related]

  • 16. Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia.
    Aribi A, Borthakur G, Ravandi F, Shan J, Davisson J, Cortes J, Kantarjian H.
    Cancer; 2007 Feb 15; 109(4):713-7. PubMed ID: 17219444
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.
    Cortes J, Kantarjian H, Albitar M, Thomas D, Faderl S, Koller C, Garcia-Manero G, Giles F, Andreeff M, O'Brien S, Keating M, Estey E.
    Cancer; 2003 Mar 01; 97(5):1234-41. PubMed ID: 12599230
    [Abstract] [Full Text] [Related]

  • 19. Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers.
    Schaefer PL, Marks RS, Mahoney MR, Sloan JA, Bauman MD, Tazelaar HD, Kugler JW, Mailliard JA, Ebbert LP, Wiesenfeld M.
    Am J Clin Oncol; 2003 Jun 01; 26(3):236-40. PubMed ID: 12796591
    [Abstract] [Full Text] [Related]

  • 20. Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
    Raza A, Mehdi M, Mumtaz M, Ali F, Lascher S, Galili N.
    Cancer; 2008 Oct 01; 113(7):1596-604. PubMed ID: 18720364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.